Literature DB >> 2549987

A rapid solution immunoassay to quantify binding of the human immunodeficiency virus envelope glycoprotein to soluble CD4.

T J McQuade1, T W Pitts, W G Tarpley.   

Abstract

We developed a particle concentration fluorescent immunoassay to quantify the binding in solution of the human immunodeficiency virus (HIV) external glycoprotein (gp120) to soluble CD4 (sCD4). The assay is rapid (1 hr), quantitative, and requires as little as 0.1 pmole of gp120 per evaluation. We find that gp120, purified from recombinant baculovirus infected insect cells, is suitable for the assay. Moreover, sCD4s obtained either from recombinant E. coli or mammalian cells, consisting of the N-terminal two domains (about 180 amino acids) as well as linked to the active regions of Pseudomonas exotoxin A, bind gp120 similarly.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2549987     DOI: 10.1016/0006-291x(89)92116-5

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  3 in total

1.  Assays to detect and characterize human immunodeficiency virus type 1 (HIV-1) receptor antagonists, compounds that inhibit binding of the HIV-1 surface glycoprotein, gp120, to the CD4 receptor on human T lymphocytes.

Authors:  J Clancy; A Tait-Kamradt; J Petitpas; M Manousos; P R McGuirk; T Subashi; P Watts; L Wondrack
Journal:  Antimicrob Agents Chemother       Date:  1994-09       Impact factor: 5.191

2.  Secretion of active truncated CD4 into Escherichia coli periplasm.

Authors:  S K Rockenbach; M J Dupuis; T W Pitts; C K Marschke; C S Tomich
Journal:  Appl Microbiol Biotechnol       Date:  1991-04       Impact factor: 4.813

3.  Interdomain interactions in the chimeric protein toxin sCD4(178)-PE40: a differential scanning calorimetry (DSC) study.

Authors:  S R Davio; K M Kienle; B E Collins
Journal:  Pharm Res       Date:  1995-05       Impact factor: 4.580

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.